Evaluation of the serum visfatin eotaxin and fetuin-A levels of patients with type 2 diabetes mellitus

dc.contributor.authorKaya, Hacer Kayhan
dc.contributor.authorŞermet, Abdurrahman
dc.contributor.authorPekkolay, Zafer
dc.contributor.authorTaşdemir, Ezel
dc.contributor.authorKeşim, Dilek Aygün
dc.date.accessioned2025-03-08T18:25:42Z
dc.date.available2025-03-08T18:25:42Z
dc.date.issued2022
dc.departmentDicle Üniversitesi
dc.description15.TIP.018 nolu proje
dc.description.abstractObjective: The aim of this study was to determine the serum visfatin, eotaxin and fetuin-A levels in patients with normal BMI and overweight type 2 diabetes mellitus (T2DM). Material and Method: This study perform in 30 T2DM patients and in 20 healthy subjects. Test subjects were divided into four groups as two diabetics and two controls. Diabetics with a body mass index (BMI) of 26.2-29.9 kg/m2 were included in the overweight diabetic group (OD), and those with a body mass index of 20.9-24.9 kg/m2 were included in the normal BMI diabetic group (ND). The volunteers in the control group were also divided into two groups as overweight (OC) and normal BMI (NC). Smoking and alcohol users were not included in the study. In addition, patients with significant diabetic complications such as retinopathy, hypertension, neuropathy, renal failure, and cardiovascular disease were excluded from the study. The serum visfatin eotaxin and fetuin-A levels were measured using the ELISA method. The Mann-Whitney U test was used to compare the data of the groups, while Spearman’s analysis was applied for the correlations. Results: The visfatin levels of the OD and ND were significantly higher compared to those of their control groups (p
dc.description.sponsorship[EN] DICLE UNIVERSTY
dc.identifier.doi10.38053/acmj.1008983
dc.identifier.endpage119
dc.identifier.issn2718-0115
dc.identifier.issue1
dc.identifier.startpage113
dc.identifier.urihttps://doi.org/10.38053/acmj.1008983
dc.identifier.urihttps://hdl.handle.net/11468/30345
dc.identifier.volume4
dc.language.isoen
dc.publisherMediHealth Academy Yayıncılık
dc.relation.ispartofAnatolian Current Medical Journal
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_DergiPark_21250205
dc.subjectVisfatin
dc.subjecteotaxin
dc.subjectfetuin-A
dc.subjecttype 2 diabetes mellitus
dc.titleEvaluation of the serum visfatin eotaxin and fetuin-A levels of patients with type 2 diabetes mellitus
dc.typeArticle

Dosyalar